SA
Go ProLog In
FENC
OverviewIntelligenceChart

Analyst Sentiment

Wall St. Consensus
Buy
7 analysts·Limited coverage
75
Score
7 Buy (100%)0 Hold (0%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
7100%
Hold
00%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$18.00
+84.6%
Consensus
$18.00
+84.6%
Bull
$18.00
+84.6%
12-Month Target Range7 analysts
$18.00$18.00$18.00
Current $9.75Consensus
Current Price
$9.75
Upside to Consensus
$8.25

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+49.09%
EPS+266.47%
FY2028
Rev+34.57%
EPS+56.24%
FY2029
Rev+41.45%
EPS+69.76%

Earnings Surprises

Recent Analyst Actions

Jan 8, 2026Piper Sandler
Fennec initiated with an Overweight at Piper Sandler
Target:$18.00
+137.5%from $7.58
Aug 15, 2025Craig-Hallum
Fennec price target raised to $14 from $13 at Craig-Hallum
Target:$14.00
+63.9%from $8.54
May 15, 2024Craig-Hallum
Fennec price target lowered to $17 from $20 at Craig-Hallum
Target:$17.00
+131.6%from $7.34
May 15, 2024H.C. Wainwright
Fennec Pharmaceuticals Inc. (FENC) PT Lowered to $15 at H.C. Wainwright
Target:$15.00
+113.4%from $7.03
Apr 4, 2024H.C. Wainwright
Fennec price target raised to $18 from $17 at H.C. Wainwright
Target:$18.00
+67.1%from $10.77
Mar 19, 2024Craig-Hallum
Fennec Pharmaceuticals Inc. (FENC) PT Raised to $18 at Craig-Hallum
Target:$18.00
+63.5%from $11.01
Nov 22, 2022Cantor Fitzgerald
Cantor Fitzgerald Upgrades Fennec Pharmaceuticals to Overweight, Raises Price Target to $12
Target:$12.00
+30.9%from $9.17
Sep 26, 2022Wedbush
Wedbush Maintains Outperform on Fennec Pharmaceuticals, Raises Price Target to $19
Target:$19.00
+167.2%from $7.11

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance